UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 212, 2012

MEDTOX SCIENTIFIC, INC.

(Exact name of registrant as specified in its charter)


Delaware	1-11394	95-3863205
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)


402 West County Road D, St. Paul, Minnesota		55112
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (651) 636-7466

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨x Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 12.0102. ~~Entry~~Results ~~into~~of aOperations ~~Material~~and ~~Definitive~~Financial ~~Agreement~~Condition

On July 212, 2012, MEDTOX ~~Laboratories, Inc., a wholly owned subsidiary of MEDTOX~~ Scientific, Inc. ~~(the~~announced ~~"Company"),~~results ~~entered~~for ~~into a Second Amendment of Lease (“Second Amendment”) to~~ the ~~Commercial~~second ~~Lease~~quarter ~~("Commercial~~ended ~~Lease")~~June ~~dated July 28~~30, ~~2000 and as amended on May 25~~2012, ~~2007, with St. Paul Properties, Inc. (“Lessor”). The Second Amendment, effective~~ as ofdescribed ~~August~~in ~~31, 2012, extends~~ the ~~term~~press ofrelease ~~the~~attached ~~lease to August 31, 2013 and provides for annual base rent rate of $154,500 per year for the period ending August 31, 2013. The Amendment is filed herewith~~ as Exhibit 1099.1 ~~and is incorporated herein by reference~~.

~~Item~~- ~~9.01. Financial~~2 ~~Statements and Exhibits.~~-

Item 8.01. Other Events

On July 12, 2012, MEDTOX Scientific, Inc. issued a press release announcing the Company’s results for the quarter ended June 30, 2012. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herewith by reference.

- 3 -

Item 9.01. Financial Statements and Exhibits.

(c)

Exhibits.

The following exhibit is filed as part of this report:

Exhibit No.		Description
10.1		Amendment of Lease dated July 2, 2012
99.1		MEDTOX Scientific, Inc. Press Release, dated July 12, 2012.

- 4 2-

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

MEDTOX Scientific, Inc.

Date: July 212, 2012 By: /s/ Richard J. Braun

Name: Richard J. Braun

Title: Chief Executive Officer

- 5 3-

INDEX TO EXHIBITS

Exhibit No.		Description
10.1		Amendment of Lease dated July 2, 2012
99.1		MEDTOX Scientific, Inc. Press Release, dated July 12, 2012.

- 6 4 -

Filing Compare · MEDTOX SCIENTIFIC INC